Public Employees Retirement System Of Ohio Mirati Therapeutics, Inc. Transaction History

Public Employees Retirement System Of Ohio

$22.6 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	BUY	$41.99 - $62.38 $181,270 - $269,294	4,317 Added 23.22%	22,908 $1.35 Million
Q3 2023 Dec 19, 2023	SELL	$27.8 - $45.35 $57,240 - $93,375	-2,059 Reduced 9.97%	18,591 $809,000
Q3 2023 Nov 15, 2023	SELL	$27.8 - $45.35 $57,240 - $93,375	-2,059 Reduced 9.97%	18,591 $810,000
Q2 2023 Dec 19, 2023	SELL	$36.13 - $49.49 $55,531 - $76,066	-1,537 Reduced 6.93%	20,650 $746,000
Q2 2023 Aug 15, 2023	SELL	$36.13 - $49.49 $55,531 - $76,066	-1,537 Reduced 6.93%	20,650 $746,000
Q1 2023 Dec 19, 2023	SELL	$36.54 - $54.26 $25,139 - $37,330	-688 Reduced 3.01%	22,187 $824,000
Q1 2023 May 15, 2023	SELL	$36.54 - $54.26 $25,139 - $37,330	-688 Reduced 3.01%	22,187 $825,000
Q4 2022 Dec 19, 2023	BUY	$41.27 - $98.62 $176,800 - $422,488	4,284 Added 23.04%	22,875 $1.04 Million
Q4 2022 Feb 15, 2023	BUY	$41.27 - $98.62 $52,866 - $126,332	1,281 Added 5.93%	22,875 $1.04 Million
Q3 2022 Nov 15, 2022	BUY	$59.5 - $86.7 $10,115 - $14,739	170 Added 0.79%	21,594 $1.51 Million
Q2 2022 Aug 15, 2022	SELL	$39.16 - $88.71 $13,236 - $29,983	-338 Reduced 1.55%	21,424 $1.44 Million
Q1 2022 May 16, 2022	SELL	$75.82 - $150.97 $60,731 - $120,926	-801 Reduced 3.55%	21,762 $1.79 Million
Q4 2021 Feb 15, 2022	BUY	$132.01 - $190.29 $86,466 - $124,639	655 Added 2.99%	22,563 $3.31 Million
Q3 2021 Nov 15, 2021	SELL	$132.13 - $177.45 $65,140 - $87,482	-493 Reduced 2.2%	21,908 $3.88 Million
Q2 2021 Aug 16, 2021	BUY	$144.0 - $179.73 $3.23 Million - $4.03 Million	22,401 New	22,401 $3.62 Million
Q1 2021 May 14, 2021	SELL	$158.92 - $221.61 $90,107 - $125,652	-567 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$162.05 - $240.27 $91,882 - $136,233	567 New	567 $125,000

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement System Of Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement System Of Ohio with notifications on news.

Account